BUSINESS
Godavari Drugs Ltd
Godavari Drugs Ltd - About the Company
Initiated in 1987, Godavari Drugs Limited produces and trades Bulk medicines in Indian market. The firm also offers agreement production facilities and is actively involved in the bulk creation of ethambutolhcl and pyrazinamide. The firm has its headquarters located in Secunderabad, India.
Godavari Drugs Limited manufactures medicines like Sulphamethoxazole which is an anti bacterial remedy with excellent potential of selling abroad. The firm is incorporated backwards to generates intermediates such as diethyl oxalate, sulphamethoxide, etc; and has even expanded its manufacturing activities of trimetroprim. Over the past few years supplementary drugs are also released in the market by the firm. Its production unit is situated in the rearward region in Maharashtra known as Nanded.
The endeavor to commence manufacturing of trimetroprim, was chiefly of premeditated attempt as both trimetroprim and sulphamethoxazole are employed in the blend to take care of an extensive range of infectivity. The firm has also released Pyrazyamide, which is a renowned product, in global market.
Godavari Drugs Ltd - Major Developments
In the year 2005, Godavari Drugs Ltd. endorsed special Issue Of Equity Shares And Merits. It declared that it has deemed and supported to increase Rs 45 million through special subscription of equity shares and merits of the firm.
In 2007, Godavari Drugs Ltd. declared allocation Of Equity Shares On exchange of merits. It later declared that it has fixed 3, 75,000 equity shares of Rs 18 per share to sponsors of the firm on exchange of remaining share merits into equity shares of the firm.
In 2009, Godavari Drugs Ltd declared selection of legislative auditors. It later declared that Daga & Co., Chartered Accountant firm based in Hyderabad, is chosen as Statutory Auditors of the firm and is deemed to begin operations after the termination of 2009 annual general meeting.
Godavari Drugs Ltd - Products
The various Bulk Drugs and Intermediates manufactured by Godavari Drugs Limited are mentioned as below:
Sulphamethizole
Enrofloxacin
Pyrazinamide
Cis
Pyrazine
Sulphamethoxazole
Naproxen
Cislactum
EthamButol Hcl
Pyrrazinamide
Isoxamine
Godavari Drugs Ltd - Financials
The financial statement of Godavari Drugs Ltd as on March 2009 is as under:
Total Revenue of the firm is computed at USD 0.736259 Millions
Market Capital of the firm is computed at ` 50.45435 Millions
Total Income of the firm is computed at ` 38.600655 Million as on March 2009
Net Profit of the firm is computed at ` -2.666956 Million as on March 2009
Other Financial details of the Godavari Drugs Ltd as on 31st March 2009 against 31st March 2008 are depicted in the table below:
Godavari Drugs Ltd - Contact Details
Registered Office:
Godavari Drugs Ltd
Sardar Patel Road
Mayfair
Secunderabad - 500003
India
Phone: 91 40 2784 9700
Fax: 91 40 2784 9859
Industrial Unit:
A 6/2. MIDC,
Nanded - 431 603
Maharashtra
Last updated on March 31, 2026
Initiated in 1987, Godavari Drugs Limited produces and trades Bulk medicines in Indian market. The firm also offers agreement production facilities and is actively involved in the bulk creation of ethambutolhcl and pyrazinamide. The firm has its headquarters located in Secunderabad, India.
Godavari Drugs Limited manufactures medicines like Sulphamethoxazole which is an anti bacterial remedy with excellent potential of selling abroad. The firm is incorporated backwards to generates intermediates such as diethyl oxalate, sulphamethoxide, etc; and has even expanded its manufacturing activities of trimetroprim. Over the past few years supplementary drugs are also released in the market by the firm. Its production unit is situated in the rearward region in Maharashtra known as Nanded.
The endeavor to commence manufacturing of trimetroprim, was chiefly of premeditated attempt as both trimetroprim and sulphamethoxazole are employed in the blend to take care of an extensive range of infectivity. The firm has also released Pyrazyamide, which is a renowned product, in global market.
Godavari Drugs Ltd - Major Developments
In the year 2005, Godavari Drugs Ltd. endorsed special Issue Of Equity Shares And Merits. It declared that it has deemed and supported to increase Rs 45 million through special subscription of equity shares and merits of the firm.
In 2007, Godavari Drugs Ltd. declared allocation Of Equity Shares On exchange of merits. It later declared that it has fixed 3, 75,000 equity shares of Rs 18 per share to sponsors of the firm on exchange of remaining share merits into equity shares of the firm.
In 2009, Godavari Drugs Ltd declared selection of legislative auditors. It later declared that Daga & Co., Chartered Accountant firm based in Hyderabad, is chosen as Statutory Auditors of the firm and is deemed to begin operations after the termination of 2009 annual general meeting.
Godavari Drugs Ltd - Products
The various Bulk Drugs and Intermediates manufactured by Godavari Drugs Limited are mentioned as below:
Godavari Drugs Ltd - Financials
The financial statement of Godavari Drugs Ltd as on March 2009 is as under:
Other Financial details of the Godavari Drugs Ltd as on 31st March 2009 against 31st March 2008 are depicted in the table below:
| 31st March 2009 | 31st March 2008 | |
| Cost of goods sold | 29.20 | 0.00 |
| Equity capital | 75.31 | 71.56 |
| EPS (Rs.) | -0.10 | -1.21 |
| OPBDIT | 9.58 | 41.21 |
| Operating margin (% of OI) | 24.7 | 100.0 |
| PAT | -0.79 | -8.68 |
| Net sales | 37.56 | 39.98 |
| Total Income | 38.78 | 41.21 |
| Other Income | 1.22 | 1.23 |
Godavari Drugs Ltd - Contact Details
Registered Office:
Godavari Drugs Ltd
Sardar Patel Road
Mayfair
Secunderabad - 500003
India
Phone: 91 40 2784 9700
Fax: 91 40 2784 9859
Industrial Unit:
A 6/2. MIDC,
Nanded - 431 603
Maharashtra
Last updated on March 31, 2026
